Essex, United Kingdom

David Edward Clark

This inventor holds 26 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Asterand UK Limited, Corcept Therapeutics Incorporated, Antabio Sas. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Edward Clark. Retrieved from https://idiyas.com/inventor/david-edward-clark

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 53.8

 

 

Average Co-Inventor Count = 8.9

ph-index = 7

Forward Citations = 188(Granted Patents)


Location History:

  • Essex, GB (2008 - 2019)
  • Margate Kent, GB (2021)
  • Harlow, GB (2007 - 2023)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Indane Derivatives
Aza-Heterocyclyl Carboxamide
Enzyme Inhibitors
Chemical Compounds
Pyrroloquinoline Compounds
Tricyclic Compounds
Glucocorticoid Receptor Modulators
EP2 Receptor Agonists
Modified Pyrimidine Compounds
Antibiotics
Microorganisms
26 patents (USPTO):Explore Patents

Title: David Edward Clark - A Pioneer in Pharmaceutical Innovations

Introduction

David Edward Clark, based in Essex, GB, is a remarkable innovator with a portfolio of 24 patents to his name. His contributions to the pharmaceutical field have focused on developing novel compounds aimed at treating various medical conditions.

Latest Patents

Among his latest inventions are notable patents that include "Aza-heterocyclyl carboxamide and related compounds and their use in treating medical conditions" and "Enzyme inhibitors." The first invention details the development of aza-heterocyclyl carboxamide compounds, which have applications in treating medical conditions such as bacterial infections by inhibiting LpxC activity. The second patent introduces innovative compounds with therapeutic applications, particularly in treating diseases where plasma kallikrein activity is involved.

Career Highlights

David has worked with several prominent companies, including Asterand UK Limited and Corcept Therapeutics Incorporated. His experience in these organizations has allowed him to refine his expertise and contribute significantly to the development of pharmaceutical innovations.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues such as George Hynd and Jonathan Mark Sutton. These partnerships have fostered a dynamic environment for research and development, further enhancing the impact of their collective work in the pharmaceutical industry.

Conclusion

David Edward Clark's inventive spirit and dedication to improving medical treatments have solidified his reputation as a leading inventor in the field. With numerous patents and a commitment to innovation, he continues to make significant strides in pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…